The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Crestor 20 mg film-coated tablets



Grunenthal Pharma LtdPA2242/016/003

Main Information

Trade NameCrestor 20 mg film-coated tablets
Active SubstancesRosuvastatin
Dosage FormFilm-coated tablet
Licence HolderGrunenthal Pharma Ltd
Licence NumberPA2242/016/003

Group Information

ATC CodeC10AA HMG CoA reductase inhibitors
C10AA07 rosuvastatin

Status

License statusAuthorised
Licence Issued17/04/2003
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0006-003-003
Interchangeable List DocumentPDF of Interchangeable List
« Back